Related Experiment Video
Updated: May 20, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
Identification of people with heterozygous familial hypercholesterolemia
1Division of Endocrinology, Metabolism, and Lipid Research, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Insights
Familial hypercholesterolemia (FH) is an underdiagnosed genetic condition increasing cardiovascular risk. Early identification and treatment are crucial for preventing premature atherosclerotic vascular disease.
Area of Science:
- Genetics
- Cardiology
- Public Health
Background:
- Familial hypercholesterolemia (FH) is an underdiagnosed autosomal codominant disorder.
- FH significantly elevates the risk of early cardiovascular disease if left untreated.
- Early diagnosis and intervention are key to mitigating this excess risk.
Purpose of the Study:
- To review the clinical challenges and strategies for identifying individuals with FH.
- To provide a clinician's perspective on FH detection.
Main Methods:
- Review of published recommendations and strategies for FH identification.
- Analysis of global approaches to FH screening.
Main Results:
- Multiple sets of recommendations for FH identification exist globally (Australasia, Europe, USA).
- Various strategies are being developed worldwide for FH case finding.
Conclusions:
- Ongoing efforts are necessary to refine FH identification methods.
- Timely diagnosis of FH is essential to prevent atherosclerotic vascular disease.
Purpose Of Review:
Familial hypercholesterolemia is an underdiagnosed autosomal codominant genetic condition associated with significantly increased risk of early cardiovascular disease when untreated. Early diagnosis and treatment decrease the excess risk, and strategies for identification of affected individuals are being developed worldwide. This review will discuss, from a clinician's perspective, some of the issues involved in identifying people with familial hypercholesterolemia.
Recent Findings:
Several sets of recommendations have been published outlining the strategies for identification of people with familial hypercholesterolemia in various countries and regions. These include Australasia, Europe, and the USA.
Summary:
Continuing efforts to find the best methods for identification of people with familial hypercholesterolemia are needed to ensure that this very treatable inherited condition is diagnosed early enough to prevent the development of atherosclerotic vascular disease.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Cholesterol: Significance and Regulation
Considering cholesterol and...
Pedigree Analysis
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...

